{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":15,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":15,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9373f12a084b","filters":{"venue":"touchREVIEWS in Neurology"}},"results":[{"id":"W2802999705","doi":"10.17925/usn.2018.14.1.47","title":"Edaravone in Amyotrophic Lateral Sclerosis’Lessons from the Clinical Development Program and the Importance of a Strategic Clinical Trial Design","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Mitsubishi Tanabe Pharma Corporation; Mallinckrodt Pharmaceuticals","keywords":"Edaravone; Amyotrophic lateral sclerosis; Medicine; Clinical trial; Drug development; Clinical study design; Cohort; Disease; Intensive care medicine; Oncology; Pharmacology; Internal medicine; Drug","authors":[{"name":"Said R. Beydoun","is_ca":false},{"name":"Jeffrey Rosenfeld","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4502577553450474,"gpt":0.4830974873236365,"spread":0.03283973197858914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007664571,0.0002656929,0.001421362,0.0000708942,0.00008355442,0.00002682106,0.0005201462,0.0002987389,0.0001496445],"category_scores_gemma":[0.001345644,0.0001335286,0.0001969727,0.000437983,0.002498907,0.00005069069,0.0003058719,0.001446365,0.00003722552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002617222,"about_ca_system_score_gemma":0.0004346812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001360418,"about_ca_topic_score_gemma":0.0005237524,"domain_scores_codex":[0.9912956,0.004486983,0.002543712,0.0007317046,0.0003755405,0.0005665118],"domain_scores_gemma":[0.9960711,0.002408485,0.0004573172,0.0008053667,0.0001081663,0.0001495864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2012847,0.003236212,0.5484468,0.0001012719,0.0002364525,0.0002076097,0.0007027941,0.00000430578,0.000397488,0.001305292,0.002018686,0.2420584],"study_design_scores_gemma":[0.05048901,0.005241458,0.9363771,0.0002423171,0.00005797753,0.00001824522,0.000007839868,0.0007229832,0.000008654058,0.001554612,0.005135476,0.0001443017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711562,0.002869247,0.00001725603,0.02111565,0.0003517646,0.004370748,0.000003145465,0.00002300886,0.00009299596],"genre_scores_gemma":[0.9771484,0.01253267,0.002082619,0.007131101,0.0005526416,0.0005016488,0.000008444945,0.00002771474,0.00001475579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3879304,"threshold_uncertainty_score":0.9207327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2492235344","doi":"10.17925/usn.2014.10.02.2","title":"Pharmacologic Decision-making in the Treatment of Focal Epilepsy—A Critical Comparison of Antiepileptic Drugs","year":2014,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft; Eisai; Valeant Pharmaceuticals International; Pfizer; Upsher-Smith; GlaxoSmithKline; Epilepsy Foundation","keywords":"Medicine; Polypharmacy; Epilepsy; Tolerability; Intensive care medicine; Antiepileptic drug; Dosing; Concomitant; Drug; Clinical trial; Psychiatry; Pharmacology; Adverse effect; Surgery; Internal medicine","authors":[{"name":"Selim R. Benbadis","is_ca":false},{"name":"Hermann Stefan","is_ca":false},{"name":"Diego Morita","is_ca":false},{"name":"Bassel Abou‐Khalil","is_ca":false},{"name":"R. Edward Hogan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05073822582231736,"gpt":0.4335016986172411,"spread":0.3827634727949238,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008109944,0.0001981468,0.001155283,0.0001935978,0.00002830354,0.000003802049,0.0002179555,0.0001111164,0.0002065541],"category_scores_gemma":[0.0008861482,0.0001154263,0.000194355,0.0003727553,0.0003287306,0.00002894213,0.00003856826,0.0002952261,0.00003090578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004412992,"about_ca_system_score_gemma":0.00005482831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003244045,"about_ca_topic_score_gemma":0.00005021839,"domain_scores_codex":[0.9969723,0.001032554,0.0009330388,0.000337877,0.0003071467,0.0004171079],"domain_scores_gemma":[0.9947425,0.004517544,0.0001417997,0.000462732,0.00005825658,0.00007719085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001525345,0.005856089,0.6430991,0.0002982569,0.00003384229,0.000219107,0.0009734687,0.00003848986,0.0003836172,0.001332498,0.0005033468,0.3457368],"study_design_scores_gemma":[0.01352743,0.05338138,0.8728105,0.0009784115,0.0004887518,0.0002289314,0.0002397857,0.01104187,0.001863585,0.00624458,0.03883762,0.0003570789],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867243,0.00835003,0.0001373081,0.001971198,0.0001536129,0.001076894,0.000003935679,0.000009297724,0.001573405],"genre_scores_gemma":[0.9927478,0.005506667,0.0006934569,0.0008239137,0.00006755171,0.0001403252,0.00000449656,0.00001215039,0.000003610599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3453797,"threshold_uncertainty_score":0.4706947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2799778697","doi":"10.17925/usn.2018.14.1.35","title":"Homocysteine Lowering with B Vitamins for Stroke Prevention—A History","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Medicine; Methylcobalamin; Vitamin B12; Cyanocobalamin; Stroke (engine); B vitamins; Homocysteine; Internal medicine; Renal function; Gastroenterology; Endocrinology","authors":[{"name":"J. David Spence","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05588673959660658,"gpt":0.3377961441035223,"spread":0.2819094045069158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003691865,0.0001540047,0.0004664721,0.0002154838,0.00003697344,0.000004045814,0.0001379097,0.0001039205,0.0004471778],"category_scores_gemma":[0.0001515141,0.0001169806,0.00009536465,0.0001535997,0.0002166207,0.00006522991,0.00005212575,0.0002647047,0.0001121632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008807881,"about_ca_system_score_gemma":0.0001499401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002281872,"about_ca_topic_score_gemma":0.0002733574,"domain_scores_codex":[0.9986588,0.00007698622,0.0003359523,0.0003718416,0.0001560256,0.0004003434],"domain_scores_gemma":[0.9992003,0.0000889704,0.00007558819,0.0004208022,0.0001193049,0.00009507877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01695937,0.004071834,0.08927514,0.006708857,0.0005791198,0.002307195,0.001644725,0.00001256674,0.1528721,0.002431857,0.1314176,0.5917197],"study_design_scores_gemma":[0.003512713,0.01227499,0.01189558,0.0001771128,0.00007520516,0.0003332045,0.000006082771,0.0002564822,0.001867446,0.0000413765,0.9693909,0.0001689693],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771464,0.007797475,0.00106678,0.001565523,0.0004243784,0.001968565,0.000005895549,0.0000610048,0.009963951],"genre_scores_gemma":[0.9768699,0.001460311,0.001600367,0.002691262,0.0006430881,0.000385289,0.00002236152,0.00006100187,0.01626639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8379733,"threshold_uncertainty_score":0.4896283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246577497","doi":"10.17925/usn.2013.09.01.35","title":"Symptomatic Treatment in Multiple Sclerosis","year":2013,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Spasticity; Quality of life (healthcare); Depression (economics); Disease; Physical medicine and rehabilitation; Balance (ability); Gait; Sexual dysfunction; Physical therapy; Psychiatry; Internal medicine","authors":[{"name":"Sandra Bigi","is_ca":true},{"name":"E Ann Yeh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1273064182057693,"gpt":0.327353612265473,"spread":0.2000471940597037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002728419,0.0002456352,0.0008879853,0.0003277479,0.00003724628,0.00001206118,0.0001462241,0.0001070716,0.0007189726],"category_scores_gemma":[0.0009774474,0.0001793217,0.0001221452,0.000418727,0.000147089,0.00008672698,0.0001088457,0.0002880727,0.0009754654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001341178,"about_ca_system_score_gemma":0.0000495417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001357652,"about_ca_topic_score_gemma":0.001016427,"domain_scores_codex":[0.9977409,0.0003708595,0.0006442851,0.0004502557,0.0001946444,0.0005990393],"domain_scores_gemma":[0.9986665,0.0005451344,0.00007922971,0.0005231408,0.00004786244,0.000138162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001026216,0.0008283336,0.7608796,0.0003015496,0.00003446085,0.00007479555,0.0004309959,0.00002206802,0.008596973,0.00002071446,0.002200915,0.2265069],"study_design_scores_gemma":[0.003503077,0.0008479192,0.9826873,0.000211103,0.00001475884,0.00002018723,0.00001814214,0.002582583,0.0002907996,0.00004616443,0.009649469,0.0001285008],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857561,0.003858293,0.000003560757,0.005546771,0.0001012299,0.00295307,0.000002339859,0.00004834379,0.001730273],"genre_scores_gemma":[0.9750376,0.02046454,0.0004384925,0.001784423,0.00006744485,0.00201586,0.000006694846,0.0000268627,0.0001580853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2263784,"threshold_uncertainty_score":0.9998024,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2487736606","doi":"10.17925/usn.2015.11.01.47","title":"Chronic Inflammatory Demyelinating Polyneuropathy in Diabetes Patients","year":2015,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"Eisai; Grifols; CSL Behring; Pfizer; Eli Lilly and Company","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Polyneuropathy; Weakness; Diabetes mellitus; Polyradiculoneuropathy; Pathophysiology; Internal medicine; Nerve conduction velocity; Gastroenterology; Surgery; Pediatrics; Guillain-Barre syndrome; Immunology; Antibody; Endocrinology","authors":[{"name":"Alon Abraham","is_ca":true},{"name":"Majed Alabdali","is_ca":true},{"name":"Mohammad Qrimli","is_ca":true},{"name":"Carolina Barnett","is_ca":true},{"name":"Hans Katzberg","is_ca":true},{"name":"Bruce A. Perkins","is_ca":true},{"name":"Vera Bril","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01984212578548503,"gpt":0.2651941285470983,"spread":0.2453520027616133,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004483924,0.0002206202,0.0005527468,0.0002159946,0.00002055039,0.000006923769,0.0001588247,0.000114474,0.00004283107],"category_scores_gemma":[0.00103563,0.0001979661,0.0000776692,0.0003635335,0.00009206153,0.00009909567,0.00012895,0.0004913064,0.00006173823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000762393,"about_ca_system_score_gemma":0.0001385802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002606314,"about_ca_topic_score_gemma":0.0003151119,"domain_scores_codex":[0.9977916,0.0003942543,0.0006401895,0.0004120983,0.000190847,0.0005709644],"domain_scores_gemma":[0.999246,0.00008224055,0.0001314935,0.0003283719,0.00005521258,0.0001566948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009338243,0.0001499481,0.9576994,0.000177443,0.000002483272,0.0001814558,0.0001763496,0.00007808232,0.0002676509,0.00004834758,0.0008089597,0.04031648],"study_design_scores_gemma":[0.00771454,0.003055775,0.7505454,0.000227611,0.00002453675,0.00002520723,0.0000251872,0.002077657,0.00006003013,0.0003904083,0.2354706,0.0003830471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888136,0.007195207,0.000001535517,0.001147611,0.0004588182,0.0006031391,0.000001392896,0.0000472411,0.001731415],"genre_scores_gemma":[0.9910426,0.001204154,0.00003195647,0.007403526,0.0001582843,0.00007528683,0.000008606986,0.00003829967,0.0000372843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2346616,"threshold_uncertainty_score":0.8072821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247336648","doi":"10.17925/usn.2011.07.01.41","title":"Stroke Rehabilitation—An Overview of Existing Guidelines and Standards of Care","year":2011,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Rehabilitation; Guideline; Stroke (engine); Best evidence; Health care; Clinical Practice; Alternative medicine; MEDLINE; Physical therapy; Intensive care medicine; Pathology","authors":[{"name":"Richard D. Zorowitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2034381036885166,"gpt":0.431363879434349,"spread":0.2279257757458323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000817858,0.0001095728,0.0006630833,0.0001799338,0.00001240346,9.963524e-7,0.00006502294,0.00008608714,0.0001646048],"category_scores_gemma":[0.00368944,0.00008735043,0.0001114915,0.0001466377,0.0002011454,0.00005436779,0.00003431062,0.0001233563,9.638029e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001972419,"about_ca_system_score_gemma":0.000117708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008317317,"about_ca_topic_score_gemma":0.00007937205,"domain_scores_codex":[0.998331,0.0002539623,0.000853311,0.0002269307,0.0002131537,0.0001217165],"domain_scores_gemma":[0.9983657,0.0003397849,0.0002243477,0.0003050683,0.0007086497,0.00005644586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00110108,0.0003402607,0.7320003,0.01005902,0.00003914398,0.00001776496,0.008537009,0.00001152929,0.002889619,0.006412552,0.0007227066,0.237869],"study_design_scores_gemma":[0.0033962,0.01349663,0.8515134,0.001750761,0.0001866927,0.00009520585,0.001690416,0.0001489308,0.001084814,0.00120812,0.1251651,0.0002636788],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9372492,0.0570221,0.00002737551,0.0003564297,0.000179442,0.0005503944,0.0000389732,0.000013638,0.004562385],"genre_scores_gemma":[0.9592143,0.01713485,0.02262048,0.0008407057,0.00006790374,0.00003987051,0.000008137848,0.00002403336,0.00004975272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2376053,"threshold_uncertainty_score":0.441687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255101771","doi":"10.17925/usn.2012.08.01.12","title":"Deep Brain Stimulation for Parkinson’s Disease—A Review","year":2012,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders; University of British Columbia","funders":"","keywords":"Deep brain stimulation; Medicine; Dyskinesia; Parkinson's disease; Disease; Intervention (counseling); Motor symptoms; Medical therapy; Physical medicine and rehabilitation; Refractory (planetary science); Intensive care medicine; Physical therapy; Neuroscience; Psychiatry; Surgery; Psychology; Pathology","authors":[{"name":"Christopher R. Honey","is_ca":true},{"name":"Manish Ranjan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04919421020952607,"gpt":0.344750848154001,"spread":0.2955566379444749,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000304893,0.0001780448,0.0005521222,0.00005691326,0.00003317524,0.000002639712,0.00007445714,0.00007168793,0.0002935368],"category_scores_gemma":[0.0008075319,0.000130949,0.0001745455,0.0001572666,0.00003840244,0.00006634295,0.00003192678,0.0001545388,0.0001015442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001390789,"about_ca_system_score_gemma":0.0000165438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002525552,"about_ca_topic_score_gemma":0.000004747479,"domain_scores_codex":[0.9985882,0.0002019726,0.0004017069,0.0003010315,0.0001016637,0.0004054162],"domain_scores_gemma":[0.9990754,0.0002798153,0.00009989018,0.0003168416,0.00002267063,0.0002054063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001126687,0.00168666,0.7528552,0.00435196,0.00003740286,0.0001080883,0.00003717629,0.00001763529,0.00004805677,0.001447812,0.03976858,0.1985147],"study_design_scores_gemma":[0.001543082,0.000602724,0.4232826,0.0002159988,0.0001707979,0.0000148964,3.255454e-7,0.0003601336,0.00000203014,0.001345993,0.5723472,0.000114308],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1708512,0.7397285,0.001013625,0.07661477,0.0007495334,0.008745895,0.00001642017,0.000136125,0.002143953],"genre_scores_gemma":[0.7098224,0.08109765,0.0005563129,0.2069415,0.0002243478,0.001036576,0.0001157922,0.00004021254,0.000165205],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6586308,"threshold_uncertainty_score":0.5339947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2482237976","doi":"10.17925/usn.2015.11.01.19","title":"Physical Activity in Pediatric Multiple Sclerosis—Can Lifestyle Factors Affect Disease Outcomes?","year":2015,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Public Health Agency; Dairy Farmers of Ontario; Public Health Agency of Canada; EMD Serono; National Multiple Sclerosis Society","keywords":"Medicine; Affect (linguistics); Multiple sclerosis; Depression (economics); Disease; Psychological intervention; Neuroinflammation; Population; Cognition; Physical activity; Physical therapy; Physical medicine and rehabilitation; Clinical psychology; Gerontology; Psychiatry; Psychology; Environmental health; Internal medicine","authors":[{"name":"E. Ann Yeh","is_ca":true},{"name":"Robert W. Motl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1576437093915405,"gpt":0.3693103030240867,"spread":0.2116665936325463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006802141,0.0003906676,0.001284157,0.0004173251,0.00004492678,0.00001432069,0.0002756038,0.0001162091,0.00002099011],"category_scores_gemma":[0.007872079,0.0002948629,0.0002537825,0.000730785,0.0001747765,0.0001227172,0.0003463992,0.0008990496,0.0000989317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001359128,"about_ca_system_score_gemma":0.0002040151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003280453,"about_ca_topic_score_gemma":0.0007103606,"domain_scores_codex":[0.9966083,0.0009376382,0.0004116912,0.0007241968,0.0005270685,0.0007911461],"domain_scores_gemma":[0.9972207,0.001229859,0.0001413877,0.000701205,0.0000738698,0.0006329659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004875723,0.0011969,0.9919394,0.0002445557,0.00001271579,0.0001109163,0.0002582095,0.00003925616,0.0002894328,0.000007332737,0.0007731158,0.004640624],"study_design_scores_gemma":[0.003442174,0.0005195274,0.9935862,0.00004947917,0.00004789125,0.000001996289,0.000007972253,0.0009668261,0.00006950045,0.00002081233,0.001081799,0.0002058605],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993236,0.001032569,0.00000519824,0.003499125,0.0002536063,0.001664032,0.00002274531,0.00007289259,0.0002138188],"genre_scores_gemma":[0.9954475,0.003145926,0.00004398218,0.0007014117,0.0002684683,0.0002951362,0.00001293184,0.00004381443,0.00004086377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007191864,"threshold_uncertainty_score":0.9999503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212945886","doi":"10.17925/usn.2021.17.2.70","title":"Innovative Therapeutic Development Programme for the Treatment of Early Alzheimer's Disease: Lecanemab (BAN2401)","year":2021,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Institute on Aging","keywords":"Disease; Alzheimer's disease; Medicine; Internal medicine","authors":[{"name":"Jeffrey L. Cummings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1204789983611148,"gpt":0.3635085386470207,"spread":0.2430295402859059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001023022,0.000215131,0.0005338627,0.00006977421,0.00005734682,0.000008931979,0.00008852661,0.00004443051,0.00005934714],"category_scores_gemma":[0.0001097729,0.0001326547,0.0001516301,0.000452417,0.0001058175,0.00002836036,0.00002315339,0.00008838223,0.00000699418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002192641,"about_ca_system_score_gemma":0.0004777528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007750767,"about_ca_topic_score_gemma":0.00003991105,"domain_scores_codex":[0.9985176,0.0001756009,0.0005116064,0.000376084,0.0001273526,0.000291789],"domain_scores_gemma":[0.9987434,0.000361396,0.0001310167,0.0004104384,0.0002631537,0.00009058193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00311228,0.004419724,0.1228094,0.0003520601,0.0006323723,0.0005286824,0.001493765,0.00001972171,0.003459313,0.001170806,0.000428606,0.8615733],"study_design_scores_gemma":[0.004384219,0.002752368,0.4286078,0.0001053547,0.0007319411,0.00005609554,0.00003038916,0.00009214684,0.02601589,0.0001166721,0.5368677,0.0002394381],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8890025,0.10422,0.0000958666,0.004177881,0.0001876749,0.002220156,0.00002085357,0.000019727,0.00005530899],"genre_scores_gemma":[0.9819509,0.009254837,0.0003463403,0.006280123,0.0001794003,0.001679845,0.0001144969,0.00003754821,0.0001565233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8613338,"threshold_uncertainty_score":0.5409502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W32808450","doi":"10.17925/usn.2010.06.01.36","title":"Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson’s Disease","year":2010,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"National Institutes of Health; Ipsen; Teva Pharmaceutical Industries","keywords":"Medicine; Levodopa; Carbidopa; Monoamine oxidase B; Parkinson's disease; Monoamine oxidase; Disease; Selegiline; Pharmacology; Pharmacotherapy; Dopamine; Internal medicine; Enzyme","authors":[{"name":"Cherian Abraham Karunapuzha","is_ca":true},{"name":"Shilpa Chitnis","is_ca":false},{"name":"Richard B. Dewey","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02569942357868454,"gpt":0.2946161251388231,"spread":0.2689167015601386,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001779592,0.0002209159,0.0005144888,0.0001685571,0.00002304793,0.000005572558,0.0001339018,0.00009073207,0.0001224434],"category_scores_gemma":[0.0001030645,0.0001355666,0.0001407876,0.0003318008,0.00008081913,0.00003830476,0.00001916575,0.0002101362,0.00005722345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002353996,"about_ca_system_score_gemma":0.00008162428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001742472,"about_ca_topic_score_gemma":0.0002509753,"domain_scores_codex":[0.9985725,0.0002000915,0.0004275063,0.0003568995,0.000157846,0.0002851008],"domain_scores_gemma":[0.9989861,0.0001078817,0.0001158021,0.0006079916,0.00002949624,0.000152712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001979444,0.005461814,0.9158067,0.0001275225,0.00004264366,0.002669571,0.000566213,0.000003254745,0.002929282,0.000553784,0.0003015718,0.06955824],"study_design_scores_gemma":[0.002453759,0.002272114,0.7624085,0.00003402741,0.0001240488,0.00002955228,0.000004361171,0.00004879701,0.0003466021,0.0003318971,0.2318526,0.00009372348],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911966,0.005629027,8.626363e-7,0.001365409,0.0003442909,0.001092364,0.00001346251,0.00001492594,0.0003430331],"genre_scores_gemma":[0.9936413,0.004912722,0.00008984822,0.0009320097,0.0001126139,0.0002149101,0.00002181975,0.00001948981,0.00005525182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2315511,"threshold_uncertainty_score":0.5528247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2490618669","doi":"10.17925/usn.2014.10.02.90","title":"Magnetic Resonance Imaging and Dopamine Transporter Single Photon Emission Tomography in Parkinson’s Disease—When Should We Use Them?","year":2014,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Magnetic resonance imaging; Dopamine transporter; Parkinson's disease; Disease; Medical diagnosis; Dopamine; Radiology; Pathology; Internal medicine; Dopaminergic","authors":[{"name":"Meir Kestenbaum","is_ca":true},{"name":"Cheryl Waters","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03341976575299417,"gpt":0.2601324053259612,"spread":0.2267126395729671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002452554,0.000314624,0.0006314937,0.0002312622,0.00003732152,0.00001777199,0.0001110162,0.00008592032,0.0001928452],"category_scores_gemma":[0.00008516985,0.0002530326,0.0001215511,0.0002322204,0.00009824575,0.0001161458,0.00004090716,0.0002672646,0.00001200125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002498011,"about_ca_system_score_gemma":0.00002388279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006575637,"about_ca_topic_score_gemma":0.00005363034,"domain_scores_codex":[0.997937,0.0002639204,0.0004786582,0.0006970464,0.0001851657,0.0004381675],"domain_scores_gemma":[0.9990174,0.00011747,0.00009185689,0.0004702793,0.00002071035,0.0002823084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006860219,0.0005319552,0.8023571,0.0001957702,0.000004139467,0.0008110704,0.00007696452,3.540964e-7,0.001057334,0.00006176746,0.0002025731,0.1940149],"study_design_scores_gemma":[0.002233902,0.0002946764,0.591469,0.0003359057,0.00008628479,0.00005324523,0.00000184614,0.0005150608,0.0001750015,0.001390075,0.4032857,0.0001592255],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9442841,0.05117721,0.00006034421,0.002949561,0.0001400254,0.0009216164,0.00002006547,0.00005226313,0.000394755],"genre_scores_gemma":[0.9831138,0.01231853,0.0005384421,0.003661196,0.00005475354,0.0001556018,0.0000261627,0.00004154903,0.00008997916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4030831,"threshold_uncertainty_score":0.9999922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944875226","doi":"10.17925/usn.2019.15.1.18","title":"Imaging, Technology, and Parkinson’s Disease","year":2019,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Deep brain stimulation; Medicine; Movement disorders; Dystonia; Essential tremor; Neuromodulation; Parkinson's disease; Neuroimaging; Translational research; Neurosurgery; Neurology; Clinical neuroscience; Neuroscience; Physical medicine and rehabilitation; Disease; Psychology; Psychiatry; Pathology; Internal medicine","authors":[{"name":"Nora Vanegas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01212401069292168,"gpt":0.2724420969306564,"spread":0.2603180862377347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007094385,0.0001496728,0.0003914004,0.0002062138,0.00001776165,0.000004607453,0.00007571239,0.0000674285,0.0002798069],"category_scores_gemma":[0.0000939653,0.0001104073,0.00005209695,0.0002480252,0.0001237639,0.00003230155,0.00008946819,0.0002589578,0.0002543343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005880505,"about_ca_system_score_gemma":0.00001756688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005446023,"about_ca_topic_score_gemma":0.000002994694,"domain_scores_codex":[0.9989578,0.00006280222,0.0002178073,0.0004359899,0.0000660439,0.0002595713],"domain_scores_gemma":[0.9994432,0.00003979006,0.0000493632,0.0003453681,0.00001284904,0.0001094459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001741872,0.000164813,0.9672586,0.00006932661,0.000005023339,0.0005745845,0.000004401511,3.949675e-7,0.00009345268,0.001068938,0.0005642211,0.03002204],"study_design_scores_gemma":[0.00173027,0.0004697141,0.7413446,0.00003015688,0.00003913077,0.00007406457,0.000001638377,0.0001215995,0.000007814018,0.007837192,0.2482491,0.00009475],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9569126,0.01841556,0.000002118663,0.02061407,0.00011627,0.0007623492,0.000002331936,0.0000612224,0.003113419],"genre_scores_gemma":[0.9758422,0.00503587,0.00006491275,0.01871135,0.00001520194,0.00006983177,0.000004366733,0.00001440555,0.0002418295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2476848,"threshold_uncertainty_score":0.4502277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2494387052","doi":"10.17925/usn.2010.06.02.96","title":"Environmental Risk Factors for Pediatric Multiple Sclerosis","year":2010,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Environmental health; Immunology; Pathology","authors":[{"name":"Naila Makhani","is_ca":true},{"name":"Brenda Banwell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02081325690780442,"gpt":0.2430942109713232,"spread":0.2222809540635188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306277,0.000174839,0.0002295004,0.00005528271,0.00006997897,0.000008486249,0.0001978166,0.0001995078,0.00006854278],"category_scores_gemma":[0.0001827661,0.0001598359,0.0001654057,0.00005469162,0.00005793013,0.000002582147,0.0001107525,0.0002399076,0.00001264342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000500931,"about_ca_system_score_gemma":0.00002062518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003307377,"about_ca_topic_score_gemma":0.0003477858,"domain_scores_codex":[0.9988313,0.00009104456,0.0002807668,0.0004334069,0.00006626784,0.0002971676],"domain_scores_gemma":[0.9993463,0.00007453687,0.0001187832,0.0003806153,0.000008715592,0.00007110598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000608128,0.0001317266,0.5389949,0.00001933644,0.000008539478,0.000001250263,0.00002234515,0.00003491697,0.4546295,0.00001136152,0.000787448,0.005297819],"study_design_scores_gemma":[0.001430682,0.000878959,0.7771413,0.000001789513,0.0000590594,0.00001242263,0.00001197292,0.0001795015,0.05442904,0.00006230848,0.1654324,0.0003605835],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974009,0.001050646,0.0002412232,0.00007441483,0.0004363153,0.0006100711,0.0001346253,0.000007047051,0.00004473842],"genre_scores_gemma":[0.9932749,0.005115591,0.0005664459,0.0004298851,0.0003361428,0.0001308131,0.0000919282,0.00002398726,0.00003032754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4002005,"threshold_uncertainty_score":0.6517917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210542383","doi":"10.17925/usn.2009.05.01.75","title":"Advances in Medical Management of Cluster Headache","year":2009,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Medicine; Cluster headache; Sumatriptan; Zolmitriptan; Methysergide; Topiramate; Triptans; Tolerability; Anesthesia; Verapamil; Migraine; Rizatriptan; Epilepsy; Internal medicine; Adverse effect; Agonist","authors":[{"name":"Stefan Evers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02287596340054963,"gpt":0.3577844737415116,"spread":0.334908510340962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004735741,0.0001167797,0.0006109083,0.0001289544,0.000009042399,7.169625e-7,0.0001072317,0.00008605845,0.0002264658],"category_scores_gemma":[0.000100671,0.00008869328,0.00007697353,0.0002553147,0.0000733525,0.0000344463,0.00005028698,0.0002978914,0.00001861322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009735122,"about_ca_system_score_gemma":0.00001997721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001437904,"about_ca_topic_score_gemma":0.0002346233,"domain_scores_codex":[0.9986646,0.000118544,0.0005509946,0.0002280979,0.0001973542,0.0002404216],"domain_scores_gemma":[0.9995683,0.00006934616,0.00006447804,0.0002277561,0.00001565357,0.00005441245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001191026,0.001475349,0.09439506,0.003106314,0.0000395833,0.002285931,0.0007752081,0.00001873447,0.0001085343,0.01008631,0.03269399,0.853824],"study_design_scores_gemma":[0.003588156,0.001590039,0.2809146,0.0008616091,0.00005552762,0.0001778932,0.00005690254,0.0001782164,0.00003871574,0.001706104,0.7106744,0.0001578376],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4342432,0.2232626,0.0001083852,0.09336261,0.0001166109,0.00198735,0.000001441982,0.00004812666,0.2468697],"genre_scores_gemma":[0.8203097,0.155833,0.0005812328,0.02269807,0.00008709014,0.00004224715,0.000003752779,0.000009049221,0.000435866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8536661,"threshold_uncertainty_score":0.3616807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249026402","doi":"10.17925/usn.2011.07.02.84","title":"Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis—A Medical, Sociological, and Media Controversy","year":2011,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Clinical trial; Skepticism; Intensive care medicine; Internal medicine; Psychiatry","authors":[{"name":"Aaron Miller","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1034316384392937,"gpt":0.2793572829191007,"spread":0.175925644479807,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008123064,0.0003070635,0.001236368,0.0002302497,0.00006962954,0.000006685805,0.0002965867,0.0004655025,0.001639413],"category_scores_gemma":[0.002061442,0.0002527376,0.0001164333,0.000370887,0.0007955499,0.00007597572,0.000211751,0.001014861,0.000130687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001325937,"about_ca_system_score_gemma":0.0002749428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005770294,"about_ca_topic_score_gemma":0.001612358,"domain_scores_codex":[0.9970177,0.0003945833,0.0008591069,0.0006893247,0.0003053577,0.0007339505],"domain_scores_gemma":[0.9986256,0.0004411306,0.0001827717,0.0004362841,0.00004061975,0.0002736305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001460614,0.01186638,0.8282564,0.001129889,0.00008652361,0.002051075,0.005675472,0.000005661841,0.005398922,0.003913498,0.002068389,0.1380871],"study_design_scores_gemma":[0.005183892,0.00808585,0.9806527,0.0003229028,0.00005501886,0.0003594507,0.00003810419,0.000335161,0.00009148211,0.0005050651,0.00408807,0.0002822373],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979811,0.01526231,0.00001465509,0.001706874,0.0003244132,0.0009258755,0.000005581974,0.00006646848,0.00188286],"genre_scores_gemma":[0.9738633,0.02125221,0.0002696166,0.004255529,0.000216959,0.00009590695,0.000008964531,0.0000314909,0.000006015523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1523963,"threshold_uncertainty_score":0.9999925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}